login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TRAWS PHARMA INC (TRAW) Stock News
USA
- NASDAQ:TRAW -
US68232V8845
-
Common Stock
2.98
USD
-0.09 (-2.93%)
Last: 10/21/2025, 7:17:50 PM
2.95
USD
-0.03 (-1.01%)
After Hours:
10/21/2025, 7:17:50 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TRAW Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Traws Pharma, Inc.
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
8 days ago - By: Traws Pharma, Inc.
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
16 days ago - By: Traws Pharma, Inc.
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
16 days ago - By: Traws Pharma, Inc.
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
2 months ago - By: The Motley Fool
- Mentions:
ONTX
Traws Pharma Posts Q2 Revenue Jump
a month ago - By: Annovis Bio Inc.
- Mentions:
ANVS
Annovis Appoints Mark Guerin as Chief Financial Officer
a month ago - By: Benzinga
- Mentions:
APRE
CODX
RNAZ
ISPC
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
2 months ago - By: Benzinga
- Mentions:
NBY
PHR
IMCC
PMN
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
2 months ago - By: Traws Pharma, Inc.
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
2 months ago - By: Traws Pharma, Inc.
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
2 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
2 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
2 months ago - By: Traws Pharma, Inc.
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
2 months ago - By: Traws Pharma, Inc.
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
4 months ago - By: Stocktwits
- Mentions:
MRNA
NVAX
CVAC
GSK
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
4 months ago - By: Traws Pharma, Inc.
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
4 months ago - By: Traws Pharma, Inc.
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
5 months ago - By: Traws Pharma, Inc.
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
5 months ago - By: Traws Pharma, Inc.
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
5 months ago - By: Traws Pharma, Inc.
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
5 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
5 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
7 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports Full Year 2024 Results and Business Highlights
7 months ago - By: Traws Pharma, Inc.
Traws Pharma Reports Full Year 2024 Results and Business Highlights
7 months ago - By: Traws Pharma, Inc.
Traws Pharma Announces Management Updates
7 months ago - By: Traws Pharma, Inc.
- Mentions:
IOVA
IKNA
Traws Pharma Announces Management Updates
7 months ago - By: Traws Pharma, Inc.
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
7 months ago - By: Traws Pharma, Inc.
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
Please enable JavaScript to continue using this application.